Coronavirus Disease 2019 and Diabetes: The Epidemic and the Korean Diabetes Association Perspective
Diabetes & Metabolism Journal
; : 372-381, 2020.
Article
de En
| WPRIM
| ID: wpr-832357
Bibliothèque responsable:
WPRO
ABSTRACT
Diabetes has been associated with more severe outcomes and higher mortality in coronavirus disease 2019 (COVID-19) patients compare to morbidity and mortality in patients without diabetes. Several mechanisms may play a role in this greater morbidity and mortality, especially uncontrolled hyperglycemia, an impaired immune system, pre-existing proinflammatory states, multiple comorbidities, and dysregulated angiotensin-converting enzyme 2 signaling. Thus, the diabetes medical community emergently needs to know about COVID-19 and its effects on patients with diabetes, as they must take precautions to carefully manage these patients during the COVID-19 pandemic. The Korean Diabetes Association provides some guidance and practical recommendations for the management of diabetes during the pandemic. This report provides insight into the association between diabetes and COVID-19, proper management of diabetes in patients with COVID-19 and an official suggestion by the Korean Diabetes Association for managing the COVID-19 outbreak.
Texte intégral:
1
Indice:
WPRIM
Type d'étude:
Guideline
langue:
En
Texte intégral:
Diabetes & Metabolism Journal
Année:
2020
Type:
Article